A closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit

Details for Australian Patent Application No. 2012213951 (hide)

Owner Novo Nordisk Health Care AG

Inventors Arentsen, Anne Charlotte; Kaersgaard, Per

Agent Shelston IP

Pub. Number AU-A-2012213951

Parent 2006239117

Filing date 14 August 2012

Wipo publication date 6 September 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/08 Medicinal preparations characterised by special physical form - Solutions

A61K 38/37 Medicinal preparations containing peptides

A61K 38/48 Medicinal preparations containing peptides

A61P 7/04 Drugs for disorders of the blood or the extracellular fluid

C12N 9/64 Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

30 August 2012 Complete Application Filed

6 September 2012 Application Open to Public Inspection

  Published as AU-A-2012213951

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012213952-Modification of flavonoid biosynthesis in plants using transparent testa 8

2012213950-Modification of flavonoid biosynthesis in plants using transparent testa 2